Satisfaction Understanding of Patients and Relatives in Emergency Room
NCT ID: NCT01848574
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1816 participants
INTERVENTIONAL
2012-02-29
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prospective observational study randomized in cluster during 6 weeks in 14 centers
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Teach Back to Improve Comprehension of Discharge Instructions for Emergency Patients With Limited Health Literacy
NCT01968291
Evaluation of Readability of Consent Forms on the Understanding of the Information Received by Volunteers
NCT03105752
Influence of a Questionnaire on Patients' Emergency Room Expectations
NCT05881434
Enhancing Empathy in Medical Communication Through Perspective-Taking
NCT00861991
Consultation in the Emergency Department
NCT01316172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is reproduced on a larger scale for in-patients in the ED concerning their comprehension about the medical information given and thus improving the scientific evidence. This study has been conducted on a national level in 2 phases with 14 investigating centers spread in Paris and other provinces:
First, an observational period was conducted during 2 weeks in each center in order to document their homogeneity. At the same time, this period permitted to have a reference level of comprehension. During this period, investigators continued to give medical information to their patients as usual. The aim is to adjust the results of the comprehensions levels in 2 groups after the experimental study on the "baseline" data.
Second, an experimental period of 4 weeks: 7 centers are identified as "formal procedure group" and their investigators are provided with formal procedures on the patient's comprehension in the ED based on updated literature data. At the same time, recommendations are given on the information given to patients. 7 other centers "control group" only formal presentation on the patient's comprehension in the ED on updated literature data.
According to the center where the patient is included, he will be either in the "formal procedure group" or the "control group".
Among all in-patients in the ED, it is planned to include:
* 700 patients in the observational period (50 in each center)
* 1400 patients in the experimental period (700 in the formal procedure group and 700 in the control group)
Improvement in the information given to patients is expected due to the participation of the centers in this study. This improvement is expected in both arms only due to the fact of their participation. Better information level is expected in the "formal procedure group".
If this study proves a better information in the procedure group, then our aim will be to propose recommendations to ED physicians to improve the information given to in-patients in the ED.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual procedure
Investigators will give medical information to their patients as usual.
No interventions assigned to this group
Experimental procedure
You must use the standardized patient information. The final Information of the patient before the final output should be clear and concise in the presence of trustworthy people if the patient wishes.
Deliver the following information in the orde of the items below:
Decline your identity and function Provide a final diagnosis, indicating the affected organ and Inform prognosis (any severity), and the potential duration of affection
Briefly additional tests:
* Radio show
* Explain the main abnormalities Explain treatment modalities and setpoint monitoring Finish with an open question: "Do you have questions? "If you think the state anxiety or depression alters the patient's understanding, still deliver all the information listed above.
standardized multifaceted information procedure to improve patients' comprehension
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standardized multifaceted information procedure to improve patients' comprehension
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inpatient Unit in Short Term Hospitalization (UHCD)
* Patient who agreed to participate in the study
* Patient affiliated to a social security scheme (beneficiary or righ)
Exclusion Criteria
* Patient in judicial restraint (certificate of non-admission in custody, incarcerated)
* Patient for which a decision forced hospitalization was taken
* Patient non-Francophone
* Patients with underlying cognitive and unable to give their consent
* Patient opposed to participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yann-Erick Claessens, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cochin Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochin Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NI10067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.